SCHEMBL15933292

SCHEMBL15933292

CC(=O)c1ncn(-c2cccc(Cl)c2F)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR1 Q9BXC0 2/20 0.48
NOTUM Q6P988 1/20 0.47
RIPK1 Q13546 3/20 0.42
MDM2 Q00987 2/20 0.40
IDO1 P14902 1/20 0.40
KAT2B Q92831 1/20 0.40
F11 P03951 4/20 0.38
KLKB1 P03952 3/20 0.38
F12 P00748 2/20 0.38
PLAT P00750 2/20 0.38
RXRA P19793 2/20 0.37
GRIN1 Q05586 2/20 0.37
GRIN2B Q13224 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
HPGD P15428 1/20 0.37
HIF1A Q16665 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GABRA1 P14867 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14692466 0.89 NOTUM (0.53) HCAR1NOTUMRIPK1MDM2IDO1
SCHEMBL15930163 0.86 HCAR1 (0.45) HCAR1NOTUMRIPK1MDM2IDO1
SCHEMBL14692520 0.84 PDE4B (0.46) HCAR1NOTUMALDH1A1CYP1A2CYP2D6
SCHEMBL15933270 0.78 PTGS2 (0.36) NOTUMRIPK1MDM2GRIN2BHPGD
SCHEMBL15933267 0.76 MAPT (0.55) NOTUMRIPK1ALDH1A1CYP1A2
SCHEMBL15933281 0.75 NPSR1 (0.52) NOTUMRIPK1MDM2ALDH1A1HPGD
SCHEMBL18204425 0.74 NOTUM (0.48) HCAR1NOTUMMDM2ALDH1A1CYP1A2
SCHEMBL15933255 0.74 NOTUM (0.45) HCAR1NOTUMRIPK1MDM2IDO1
SCHEMBL14691598 0.73 RIPK1 (0.53) NOTUMRIPK1MDM2ALDH1A1
SCHEMBL15933238 0.71 RIPK1 (0.46) NOTUMRIPK1MDM2IDO1KAT2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170158712-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-06-08 US disclosed
EP-2739628-B1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-06-07 EP disclosed
US-9611274-B2 Macrocycles as factor XIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-04-04 US disclosed
US-20160068544-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2016-03-10 US disclosed
US-9221818-B2 Macrocycles as factor XIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2015-12-29 US disclosed
US-20140221338-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068544-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS TFPI, TFPI2, F12 HCAR1 3123/4885NOTUM 2506/4885RIPK1 773/4885
US-20140221338-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS TFPI, TFPI2, F12 HCAR1 3123/4885NOTUM 2506/4885RIPK1 773/4885
US-20170158712-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS TFPI, TFPI2, F12 HCAR1 3123/4885NOTUM 2506/4885RIPK1 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.